The methods you use for blood collection and processing will impact on the EVs that end up
in your isolated sample. Here we discuss the evidence to help you make the right decisions …

Extracellular vesicles (EVs) in human blood are a potential source of biomarkers. To which
extent anticoagulation affects their concentration, cellular origin and protein composition is …

Extracellular vesicles (EVs) are widely studied as a system of intercellular communication,
as markers of various diseases, as well as a vehicle for delivery of various bioactive …

Extracellular vesicles (EVs) participate in thrombosis via the functions of molecule
expression on their surfaces, including tissue factor (TF) and phosphatidylserine (PS). TF is …

Extracellular vesicles (EVs) isolated from plasma are increasingly recognized as promising
circulating biomarkers for disease discovery and progression, as well as for therapeutic drug …

Method We used our optimized IFCM method and a panel of 20 different antibodies covering
a cross-section of EV origin to investigate the preanalytics of EV preparation from whole …

Background Plasma and other body fluids contain membranous extracellular vesicles (EVs),
which are considered to derive from activated or apoptotic cells. EVs participate in …

Extracellular vesicles (EVs) comprising both nanovesicles (or exosomes) and microvesicles
(MVs)(or microparticles) are found in plasma and other body fluids. The much smaller …

Background Blood plasma is available with minimal invasive sampling, it has significant
diagnostic utility, and it is a valuable source of extracellular vesicles (EVs). Nevertheless …

Blood is the most commonly used body fluid for obtaining and studying extracellular vesicles
(EVs). While blood is a standard choice for clinical analysis, using blood as a source of EVs …